IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV
- 15 December 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (1) , e221-e229
Abstract
Background: Fractures are common in people with HIV (PWH). Interleukin 4 (IL-4), an antiosteoclastogenic product of CD4 Th2 T cells, becomes depleted in PWH; however, its role in skeletal deterioration in PWH is unknown. We therefore examined associations between IL-4 and bone mineral density (BMD), bone resorption and formation markers (β-C-terminal telopeptide of type I collagen and osteocalcin), and the osteoclastogenic regulators receptor activator of NF-κB ligand (RANKL) and osteoprotegerin in PWH who were antiretroviral therapy (ART) naive and people without HIV (PWoH). Methods: Commercial enzyme-linked immunosorbent assays were used to measure factors in a cohort of 37 ART-naive PWH and 28 PWoH and in an independent cohort of 29 ART-experienced PWH. BMD was quantified by bone densitometry, and IL-4 associations were analyzed by sex and HIV status via Spearman correlation and multivariable linear regression. Results: IL-4 was significantly lower in ART-naive PWH as compared with PWoH and higher in ART-experienced PWH vs ART-naive PWH. With ART-naive PWH and PWoH combined, IL-4 correlated inversely with β-C-terminal telopeptide of type I collagen, RANKL, and RANKL/osteoprotegerin ratio in males and females, individually and when aggregated, but not in ART-naive PWH or PWoH individually. In PWoH and ART-naive PWH combined, IL-4 was significantly associated with higher lumbar spine Z score and most femoral BMD T and Z scores in males but not females. Conclusions: IL-4 levels are reduced in treatment-naive PWH and higher in ART-experienced PWH. IL-4 positively correlates with BMD in men but not women, suggesting that IL-4 protects the male skeleton and that IL-4 decline may contribute to bone loss in men with HIV.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR059364)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR070091)
This publication has 48 references indexed in Scilit:
- Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United StatesJBMR Plus, 2019
- IL‐4 gene polymorphisms and their relation to steroid‐induced osteonecrosis of the femoral head in Chinese populationMolecular Genetics & Genomic Medicine, 2019
- Bone Loss Among Women Living With HIVCurrent HIV/AIDS Reports, 2016
- Interleukin‐4 inhibits RANKL‐induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesisJournal of Cellular Biochemistry, 2011
- Risk-Adjusted Mortality Rates of Elderly Veterans with Hip FracturesAnnals of Epidemiology, 2007
- Reduced cortical bone mass in mice with inactivation of interleukin‐4 and interleukin‐13Journal of Orthopaedic Research, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Interleukin-4 as a bone regulatory factor: Effects on murine osteoblast-like cellsJournal of Endocrinological Investigation, 1995
- Interleukin 4 receptor: signaling mechanismsImmunology Today, 1994
- Interleukin-4 as a potent inhibitor of bone resorptionBiochemical and Biophysical Research Communications, 1990